Customer engagement and pharma’s field force futureHow healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s Share XCustomer engagement and pharma’s field force futurehttps://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/
AI, big data and deep real-world evidence – the challenges and opportunitiesReal-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights Share XAI, big data and deep real-world evidence – the challenges and opportunitieshttps://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/
Virtual trials and the next generation of pharma clinical researchPreviously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a Share XVirtual trials and the next generation of pharma clinical researchhttps://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/
First Psychiatry Consortium funded project announced for schizophreniaA partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Share XFirst Psychiatry Consortium funded project announced for schizophreniahttps://pharmaphorum.com/partner-content/first-psychiatry-consortium-funded-project-announced-for-schizophrenia/
Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/
Increasing patient engagement with UK clinical trialsPharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Introducing the new NIHR National Patient Recruitment CentresThe five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Clinical decision-making insights for haem/oncsDespite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several Share XClinical decision-making insights for haem/oncshttps://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/
How to win with a multichannel approach in pharmaA multichannel marketing approach, together with compelling content, is the ultimate way for pharma to deliver the message Share XHow to win with a multichannel approach in pharmahttps://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/
